Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Bioinformatics Analysis of Omics Data for Biomarker Identification in Clinical Research, Volume II
This Research Topic is part of a series with, "Bioinformatics Analysis of Omics Data for Biomarker Identification in Clinical Research - Volume I" (https://www.frontiersin.org/research-topics/13816/bioinformatics-analysis-of-omics-data-for-biomarker-identification-in-clinical-research) The advances and the decreasing cost of omics data enable profiling of disease molecular features at different levels, including bulk tissues, animal models, and single cells. Large volumes of omics data enhance the ability to search for information for preclinical study and provide the opportunity to leverage them to understand disease mechanisms, identify molecular targets for therapy, and detect biomarkers ...
Liner Conferences in Competition Law
A liner conference, as a self-regulation organisational form of liner shipping companies, constitutes a typical "hard-core cartel" with significant anti-competitive effect. One of the main three trade routes of liner shipping traffic is the Europe-Asia Trade, on the two ends of which both the European Community (EC) and the People’s Republic of China (PRC) play important roles in the international liner shipping market. However, the competition regimes on liner conferences in both jurisdictions are not equivalent. From a comparative point of view, this book reviews the historical development of maritime policy and regulatory legislation in the EC and the PRC, catches insight into the system of regulation regime and individual provisions in substantive and procedural meaning, and finally provides a wide-ranging perspective on the future competition regulation in respect of the latest developments in both jurisdictions.
State and Ethnicity in China's Southwest
Twentieth century China has seen local societies undergo unprecedented transformations accompanied by a remarkable continuity in state practice. In this path-breaking study of two ethnically different communities, the matrilineal Mosuo and the patrilineal Han, in northwest Yunnan province, the author traces cultural change from a historical perspective in relation to the ecological environment and political systems. The treatment of state penetration into local society challenges the conventional binary narratives of state-society and Han/non-Han relations. With its interdisciplinary approach, the book enriches the anthropology of China by framing ethnicity issues in terms of local politics and inter-relationships between levels of government, and at the same time extends the analytical perimeter of the study of the Chinese state to the national periphery.
5G NR and Enhancements
5G NR and Enhancements: From R15 to R16 introduces 5G standards, along with the 5G standardization procedure. The pros and cons of this technical option are reviewed, with the reason why the solution selected explained. The book's authors are 3GPP delegates who have been working on 4G/5G standardization for over 10 years. Their experience with the 5G standardization process will help readers understand the technology. Thousands of 3GPP papers and dozens of meeting minutes are also included to help explain how the 5G stand came into form. - Provides a complete introduction to 5G standards, including Release 15 and 16, the essential vertical features URLLC, V2X and unlicensed spectrum access - Introduces the 5G standardization procedure, along with the pros, cons and technical options - Explains the "balance system design principle from the 5G standardization procedure - Presents a vision of 5G R17 and 6G
Cancer Immunology and Immunotherapy
Delivery Technologies for Immuno-Oncology: Volume 1: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for...
